{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:53:44Z","timestamp":1788386024358,"version":"build-2803163510"},"reference-count":142,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T00:00:00Z","timestamp":1659225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Novelgen Company","award":["S-2018-1158-000"],"award-info":[{"award-number":["S-2018-1158-000"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Outbreaks of viral diseases, which cause morbidity and mortality in animals and humans, are increasing annually worldwide. Vaccines, antiviral drugs, and antibody therapeutics are the most effective tools for combating viral infection. The ongoing coronavirus disease 2019 pandemic, in particular, raises an urgent need for the development of rapid and broad-spectrum therapeutics. Current antiviral drugs and antiviral antibodies, which are mostly specific at protein levels, have encountered difficulties because the rapid evolution of mutant viral strains resulted in drug resistance. Therefore, degrading viral genomes is considered a novel approach for developing antiviral drugs. The current article highlights all potent candidates that exhibit antiviral activity by digesting viral genomes such as RNases, RNA interference, interferon-stimulated genes 20, and CRISPR\/Cas systems. Besides that, we introduce a potential single-chain variable fragment (scFv) that presents antiviral activity against various DNA and RNA viruses due to its unique nucleic acid hydrolyzing characteristic, promoting it as a promising candidate for broad-spectrum antiviral therapeutics.<\/jats:p>","DOI":"10.3390\/microorganisms10081552","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T04:04:00Z","timestamp":1659326640000},"page":"1552","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Novel Approach of Antiviral Drugs Targeting Viral Genomes"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4343-7475","authenticated-orcid":false,"given":"Phuong Thi","family":"Hoang","sequence":"first","affiliation":[{"name":"Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Gyeonggi-do, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh Xuan Thi","family":"Luong","sequence":"additional","affiliation":[{"name":"Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Gyeonggi-do, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramadhani Qurrota","family":"Ayun","sequence":"additional","affiliation":[{"name":"Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Gyeonggi-do, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Gyeonggi-do, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-8721","authenticated-orcid":false,"given":"Thuy Thi Bich","family":"Vo","sequence":"additional","affiliation":[{"name":"Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Gyeonggi-do, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Novelgen Co., Ltd., R&D Center, 77, Changnyong-daero 256 Beon-gil, Yeongtong-gu, Suwon 16229, Gyeonggi-do, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukchan","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Gyeonggi-do, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,31]]},"reference":[{"key":"ref_1","unstructured":"WHO (2022). Coronavirus Disease (COVID-19) Dashboard, WHO."},{"key":"ref_2","unstructured":"WHO (2015). Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003, World Health Organization."},{"key":"ref_3","unstructured":"WHO (2022). Middle East Respiratory Syndrome Coronavirus (MERS-CoV)\u2014Saudi Arabia, WHO."},{"key":"ref_4","unstructured":"WHO (2020). Ebola in Democratic Republic of Congo\u2014North Kivu, Ituri 2018\u20132020, WHO."},{"key":"ref_5","unstructured":"WHO (2022). Ebola Virus Disease-Democratic Republic of Congo, WHO."},{"key":"ref_6","unstructured":"WHO (2020). Latest HIV Estimates and Updates on HIV Policies Uptake, July 2020, WHO."},{"key":"ref_7","unstructured":"WHO (2017). Global Hepatitis Report, 2017, WHO."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","unstructured":"WHO (2022). Avian Influenza A (H5N1)\u2014United States of America, WHO."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","article-title":"Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs","volume":"172","author":"Tompa","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1074\/mcp.M117.067116","article-title":"Identifying Host Factors Associated with DNA Replicated During Virus Infection","volume":"16","author":"Reyes","year":"2017","journal-title":"Mol. Cell. Proteom."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.cell.2020.10.019","article-title":"Translation and Replication Dynamics of Single RNA Viruses","volume":"183","author":"Boersma","year":"2020","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.cell.2021.02.013","article-title":"Antivirals with common targets against highly pathogenic viruses","volume":"184","author":"Lu","year":"2021","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2018.01581","article-title":"Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement","volume":"9","author":"Dou","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved Antiviral Drugs over the Past 50 Years","volume":"29","author":"Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.idc.2010.01.001","article-title":"Antiviral drug resistance: Mechanisms and clinical implications","volume":"24","author":"Strasfeld","year":"2010","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","article-title":"Influenza and antiviral resistance: An overview","volume":"39","author":"Lampejo","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.tibtech.2019.09.009","article-title":"Next-Generation Sequencing: An Eye-Opener for the Surveillance of Antiviral Resistance in Influenza","volume":"38","author":"Saelens","year":"2020","journal-title":"Trends Biotechnol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8503","DOI":"10.1021\/acs.est.0c03105","article-title":"Potential Emergence of Antiviral-Resistant Pandemic Viruses via Environmental Drug Exposure of Animal Reservoirs","volume":"54","author":"Kumar","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/2211-5463.12167","article-title":"Comparative interactomics for virus-human protein-protein interactions: DNA viruses versus RNA viruses","volume":"7","year":"2017","journal-title":"FEBS Open Bio"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"12720","DOI":"10.1128\/JVI.01471-07","article-title":"Viral encounters with 2\u2019,5\u2019-oligoadenylate synthetase and RNase L during the interferon antiviral response","volume":"81","author":"Silverman","year":"2007","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/21505594.2021.1871823","article-title":"Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses","volume":"12","author":"Li","year":"2021","journal-title":"Virulence"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1134\/S0026893314040050","article-title":"Ribonucleases as antiviral agents","volume":"48","author":"Ilinskaya","year":"2014","journal-title":"Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1073\/pnas.96.6.2678","article-title":"Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin","volume":"96","author":"Huang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1128\/JVI.02953-14","article-title":"RNase L targets distinct sites in influenza A virus RNAs","volume":"89","author":"Cooper","year":"2015","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1128\/JVI.80.6.2987-2999.2006","article-title":"RNase L plays a role in the antiviral response to West Nile virus","volume":"80","author":"Scherbik","year":"2006","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1128\/JVI.00489-06","article-title":"PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons","volume":"80","author":"Samuel","year":"2006","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/nar\/gkt019","article-title":"MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation","volume":"41","author":"Lin","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.1400337","article-title":"MCPIP1 suppresses hepatitis C virus replication and negatively regulates virus-induced proinflammatory cytokine responses","volume":"193","author":"Lin","year":"2014","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Sorgeloos, F., Jha, B.K., Silverman, R.H., and Michiels, T. (2013). Evasion of Antiviral Innate Immunity by Theiler\u2019s Virus L* Protein through Direct Inhibition of RNase L. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003474"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"eabh2479","DOI":"10.1126\/sciadv.abh2479","article-title":"RNase L limits host and viral protein synthesis via inhibition of mRNA export","volume":"7","author":"Burke","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-5793(03)00225-4","article-title":"Cytotoxic ribonucleases: Molecular weapons and their targets","volume":"540","author":"Makarov","year":"2003","journal-title":"FEBS Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e1976","DOI":"10.1002\/rmv.1976","article-title":"A review on current status of antiviral siRNA","volume":"28","author":"Qureshi","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/14712598.8.4.449","article-title":"RNA interference and its therapeutic potential against HIV infection","volume":"8","author":"Singh","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.2144\/000112167","article-title":"RNAi as a treatment for HIV-1 infection","volume":"40","author":"Rossi","year":"2006","journal-title":"BioTechniques"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1073\/pnas.0437841100","article-title":"RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription","volume":"100","author":"Ge","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.antiviral.2007.12.010","article-title":"PA subunit of RNA polymerase as a promising target for anti-influenza virus agents","volume":"78","author":"Nakazawa","year":"2008","journal-title":"Antivir. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.cr.7290286","article-title":"Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs","volume":"15","author":"Shi","year":"2005","journal-title":"Cell Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1385\/MB:33:2:141","article-title":"Identification of effective siRNA blocking the expression of SARS viral envelope E and RDRP genes","volume":"33","author":"Meng","year":"2006","journal-title":"Mol. Biotechnol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/hep.1840380410","article-title":"Inhibition of HBV replication by siRNA in a stable HBV-producing cell line","volume":"38","author":"Konishi","year":"2003","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/10611860701878750","article-title":"siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection","volume":"16","author":"Chen","year":"2008","journal-title":"J. Drug Target."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1158\/1535-7163.MCT-08-0626","article-title":"Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs","volume":"8","author":"Bousarghin","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kumar, P., Lee, S.K., Shankar, P., and Manjunath, N. (2006). A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med., 3.","DOI":"10.1371\/journal.pmed.0030096"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e2001650","DOI":"10.1002\/adhm.202001650","article-title":"siRNA Therapeutics against Respiratory Viral Infections-What Have We Learned for Potential COVID-19 Therapies?","volume":"10","author":"Mehta","year":"2021","journal-title":"Adv. Healthc Mater."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3851\/IMP1798","article-title":"RNA Interference and Its Potential Applications to Chronic HBV Treatment: Results of a Phase I Safety and Tolerability Study","volume":"16","author":"Gish","year":"2011","journal-title":"Antivir. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"DeVincenzo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40259-013-0046-1","article-title":"Emerging targets and novel approaches to Ebola virus prophylaxis and treatment","volume":"27","author":"Choi","year":"2013","journal-title":"BioDrugs"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1038\/sj.onc.1207586","article-title":"The exonuclease ISG20 is directly induced by synthetic dsRNA via NF-kappaB and IRF1 activation","volume":"23","author":"Espert","year":"2004","journal-title":"Oncogene"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"19457","DOI":"10.1074\/jbc.272.31.19457","article-title":"Molecular cloning of a new interferon-induced PML nuclear body-associated protein","volume":"272","author":"Gongora","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1348-0421.2008.00004.x","article-title":"Expression of interferon-stimulated gene 20 in vascular endothelial cells","volume":"52","author":"Imaizumi","year":"2008","journal-title":"Microbiol. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1093\/nar\/25.24.5110","article-title":"The proofreading domain of Escherichia coli DNA polymerase I and other DNA and\/or RNA exonuclease domains","volume":"25","author":"Moser","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1021\/bi010141t","article-title":"The human interferon- and estrogen-regulated ISG20\/HEM45 gene product degrades single-stranded RNA and DNA in vitro","volume":"40","author":"Nguyen","year":"2001","journal-title":"Biochemistry"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.febslet.2004.09.074","article-title":"Crystal structure of human ISG20, an interferon-induced antiviral ribonuclease","volume":"577","author":"Horio","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5582\/irdr.2017.01004","article-title":"Interferon-stimulated gene 20-kDa protein (ISG20) in infection and disease: Review and outlook","volume":"6","author":"Zheng","year":"2017","journal-title":"Intractable Rare Dis. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"605024","DOI":"10.3389\/fimmu.2020.605024","article-title":"All About the RNA: Interferon-Stimulated Genes That Interfere With Viral RNA Processes","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"68179","DOI":"10.18632\/oncotarget.11907","article-title":"Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo","volume":"7","author":"Leong","year":"2016","journal-title":"Oncotarget"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Imam, H., Kim, G.W., Mir, S.A., Khan, M., and Siddiqui, A. (2020). Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008338"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1073\/pnas.1808319115","article-title":"N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle","volume":"115","author":"Imam","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","article-title":"A Unified Model for the Function of YTHDF Proteins in Regulating m(6)A-Modified mRNA","volume":"181","author":"Zaccara","year":"2020","journal-title":"Cell"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Wu, N., Nguyen, X.N., Wang, L., Appourchaux, R., Zhang, C., Panthu, B., Gruffat, H., Journo, C., Alais, S., and Qin, J. (2019). The interferon stimulated gene 20 protein (ISG20) is an innate defense antiviral factor that discriminates self versus non-self translation. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1008093"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e00209-18","DOI":"10.1128\/mSphere.00209-18","article-title":"The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins","volume":"3","author":"Weiss","year":"2018","journal-title":"mSphere"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2010.10.008","article-title":"Antiviral activities of ISG20 in positive-strand RNA virus infections","volume":"409","author":"Zhou","year":"2011","journal-title":"Virology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"16151","DOI":"10.1074\/jbc.M209628200","article-title":"ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses","volume":"278","author":"Espert","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1128\/JVI.02199-09","article-title":"Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections","volume":"84","author":"Jiang","year":"2010","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/JVI.02113-07","article-title":"Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus","volume":"82","author":"Jiang","year":"2008","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrmicro3279","article-title":"Unravelling the structural and mechanistic basis of CRISPR-Cas systems","volume":"12","author":"Westra","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"20150496","DOI":"10.1098\/rstb.2015.0496","article-title":"CRISPR-Cas: Biology, mechanisms and relevance","volume":"371","author":"Hille","year":"2016","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"745559","DOI":"10.3389\/fgeed.2021.745559","article-title":"The Application of CRISPR\/Cas Systems for Antiviral Therapy","volume":"3","author":"Baddeley","year":"2021","journal-title":"Front. Genome Ed."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3389\/fbioe.2020.00841","article-title":"CRISPR\/Cas12a Mediated Genome Editing Enhances Bombyx mori Resistance to BmNPV","volume":"8","author":"Dong","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1093\/nar\/gkaa226","article-title":"Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA","volume":"48","author":"Gao","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.omtn.2018.05.021","article-title":"Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice","volume":"12","author":"Bella","year":"2018","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virusres.2016.08.001","article-title":"Pseudorabies virus can escape from CRISPR-Cas9-mediated inhibition","volume":"223","author":"Peng","year":"2016","journal-title":"Virus Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1099\/vir.0.000159","article-title":"Inhibition of hepatitis B virus by the CRISPR\/Cas9 system via targeting the conserved regions of the viral genome","volume":"96","author":"Liu","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","article-title":"Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA","volume":"156","author":"Nishimasu","year":"2014","journal-title":"Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1039\/D0SC06973F","article-title":"CRISPR technology incorporating amplification strategies: Molecular assays for nucleic acids, proteins, and small molecules","volume":"12","author":"Feng","year":"2021","journal-title":"Chem. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"180017","DOI":"10.1038\/sdata.2018.17","article-title":"Epidemiological characteristics of human-infective RNA viruses","volume":"5","author":"Woolhouse","year":"2018","journal-title":"Sci. Data"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1098\/rstb.2011.0354","article-title":"Human viruses: Discovery and emergence","volume":"367","author":"Woolhouse","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2017.06.050","article-title":"The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a","volume":"170","author":"Liu","year":"2017","journal-title":"Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.molcel.2019.09.013","article-title":"Programmable Inhibition and Detection of RNA Viruses Using Cas13","volume":"76","author":"Freije","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/srep02510","article-title":"Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus","volume":"3","author":"Ebina","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1073\/pnas.1405186111","article-title":"RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection","volume":"111","author":"Hu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/QAD.0000000000001079","article-title":"Functional screening of guide RNAs targeting the regulatory and structural HIV-1 viral genome for a cure of AIDS","volume":"30","author":"Yin","year":"2016","journal-title":"AIDS"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"743580","DOI":"10.3389\/fmicb.2021.743580","article-title":"Potential Use of CRISPR\/Cas13 Machinery in Understanding Virus\u2013Host Interaction","volume":"12","author":"Bayoumi","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nature24049","article-title":"RNA targeting with CRISPR\u2013Cas13","volume":"550","author":"Abudayyeh","year":"2017","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1126\/science.aas8836","article-title":"Field-deployable viral diagnostics using CRISPR-Cas13","volume":"360","author":"Myhrvold","year":"2018","journal-title":"Science"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2018.02.033","article-title":"Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors","volume":"173","author":"Konermann","year":"2018","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41587-021-00822-w","article-title":"Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents","volume":"39","author":"Blanchard","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Bawage, S.S., Tiwari, P.M., and Santangelo, P.J. (2018). Synthetic mRNA expressed Cas13a mitigates RNA virus infections. bioRxiv.","DOI":"10.1101\/370460"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1093\/nar\/gkac159","article-title":"CRISPR\/Cas13 effectors have differing extents of off-target effects that limit their utility in eukaryotic cells","volume":"50","author":"Ai","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41598-018-19626-1","article-title":"Efficient inhibition of African swine fever virus replication by CRISPR\/Cas9 targeting of the viral p30 gene (CP204L)","volume":"8","author":"Petersen","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"23146","DOI":"10.1038\/srep23146","article-title":"Inhibition of HSV-1 Replication by Gene Editing Strategy","volume":"6","author":"Roehm","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12985-016-0600-9","article-title":"The mutated tegument protein UL7 attenuates the virulence of herpes simplex virus 1 by reducing the modulation of \u03b1-4 gene transcription","volume":"13","author":"Xu","year":"2016","journal-title":"Virol. J."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"van Diemen, F.R., Kruse, E.M., Hooykaas, M.J.G., Bruggeling, C.E., Sch\u00fcrch, A.C., van Ham, P.M., Imhof, S.M., Nijhuis, M., Wiertz, E.J.H.J., and Lebbink, R.J. (2016). CRISPR\/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005701"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1134\/S0026893319010059","article-title":"A Plasmid-Expressed CRISPR\/Cas9 System Suppresses Replication of HSV Type I in a Vero Cell Culture","volume":"53","author":"Karpov","year":"2019","journal-title":"Mol. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41587-020-00781-8","article-title":"Targeting herpes simplex virus with CRISPR\u2013Cas9 cures herpetic stromal keratitis in mice","volume":"39","author":"Yin","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/gt.2016.41","article-title":"Excision of HIV-1 DNA by gene editing: A proof-of-concept in vivo study","volume":"23","author":"Kaminski","year":"2016","journal-title":"Gene Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"22555","DOI":"10.1038\/srep22555","article-title":"Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR\/Cas9 Gene Editing","volume":"6","author":"Kaminski","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virusres.2018.04.002","article-title":"Genome scale screening identification of SaCas9\/gRNAs for targeting HIV-1 provirus and suppression of HIV-1 infection","volume":"250","author":"Wang","year":"2018","journal-title":"Virus Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.ymthe.2017.03.012","article-title":"In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models","volume":"25","author":"Yin","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"103678","DOI":"10.1016\/j.ebiom.2021.103678","article-title":"CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination","volume":"73","author":"Herskovitz","year":"2021","journal-title":"EBioMedicine"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.omtn.2020.05.030","article-title":"CRISPR-Cas13a Inhibits HIV-1 Infection","volume":"21","author":"Yin","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2015.03.015","article-title":"Targeting hepatitis B virus cccDNA by CRISPR\/Cas9 nuclease efficiently inhibits viral replication","volume":"118","author":"Dong","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00018-019-03021-8","article-title":"Orthologous CRISPR\/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus","volume":"76","author":"Kostyushev","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"665184","DOI":"10.3389\/fmicb.2021.665184","article-title":"Inhibition of Hepatitis B Virus by AAV8-Derived CRISPR\/SaCas9 Expressed From Liver-Specific Promoters","volume":"12","author":"Yan","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1007\/s00705-017-3553-4","article-title":"CRISPR\/Cas9-mediated multiple single guide RNAs potently abrogate pseudorabies virus replication","volume":"162","author":"Tang","year":"2017","journal-title":"Arch. Virol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.ymthe.2019.08.012","article-title":"Systemic Delivery of CRISPR\/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors","volume":"27","author":"Jubair","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbrc.2014.07.014","article-title":"In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR\/Cas9","volume":"450","author":"Zhen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jconrel.2020.02.045","article-title":"Hyperbranched poly(\u03b2-amino ester) based polyplex nanopaticles for delivery of CRISPR\/Cas9 system and treatment of HPV infection associated cervical cancer","volume":"321","author":"Gao","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_111","first-page":"2197","article-title":"CRISPR\/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6","volume":"17","author":"Yoshiba","year":"2019","journal-title":"Oncol Lett."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1128\/JVI.01879-14","article-title":"Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR\/Cas RNA-guided endonuclease","volume":"88","author":"Kennedy","year":"2014","journal-title":"J. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7150\/thno.51479","article-title":"Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41422-020-0290-0","article-title":"Virus against virus: A potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses","volume":"30","author":"Nguyen","year":"2020","journal-title":"Cell Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1038\/s41598-020-66775-3","article-title":"Abrogation of PRRSV infectivity by CRISPR-Cas13b-mediated viral RNA cleavage in mammalian cells","volume":"10","author":"Cui","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1081\/IMM-120016241","article-title":"Production and characterization of an anti-idiotypic single chain Fv that recognizes an anti-DNA antibody","volume":"31","author":"Kwon","year":"2002","journal-title":"Immunol. Investig."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1074\/jbc.M600937200","article-title":"Heavy and light chain variable single domains of an anti-DNA binding antibody hydrolyze both double- and single-stranded DNAs without sequence specificity","volume":"281","author":"Kim","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"773","DOI":"10.14348\/molcells.2015.0073","article-title":"Therapeutic Strategy for the Prevention of Pseudorabies Virus Infection in C57BL\/6 Mice by 3D8 scFv with Intrinsic Nuclease Activity","volume":"38","author":"Lee","year":"2015","journal-title":"Mol. Cells"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Lee, G., Yu, J., Cho, S., Byun, S.J., Kim, D.H., Lee, T.K., Kwon, M.H., and Lee, S. (2014). A nucleic-acid hydrolyzing single chain antibody confers resistance to DNA virus infection in hela cells and C57BL\/6 mice. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004208"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Lee, Y., Hoang, P.T., Kim, D., Ayun, R.Q., Luong, Q.X.T., Na, K., Kim, T., Oh, Y., Kim, W.-K., and Lee, S. (2022). A Therapeutically Active Minibody Exhibits an Antiviral Activity in Oseltamivir-Resistant Influenza-Infected Mice via Direct Hydrolysis of Viral RNAs. Viruses, 14.","DOI":"10.3390\/v14051105"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1007\/s00253-014-6257-7","article-title":"Development of Lactobacillus paracasei harboring nucleic acid-hydrolyzing 3D8 scFv as a preventive probiotic against murine norovirus infection","volume":"99","author":"Hoang","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00299-009-0758-3","article-title":"Production of recombinant single chain antibodies (scFv) in vegetatively reproductive Kalanchoe pinnata by in planta transformation","volume":"28","author":"Jung","year":"2009","journal-title":"Plant Cell Rep."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.abb.2017.09.004","article-title":"The catalytic activity of a recombinant single chain variable fragment nucleic acid-hydrolysing antibody varies with fusion tag and expression host","volume":"633","author":"Lee","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"14373","DOI":"10.1038\/s41598-017-14793-z","article-title":"Heparan sulfate proteoglycans (HSPGs) and chondroitin sulfate proteoglycans (CSPGs) function as endocytic receptors for an internalizing anti-nucleic acid antibody","volume":"7","author":"Park","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00018-009-9179-2","article-title":"A nucleic acid-hydrolyzing antibody penetrates into cells via caveolae-mediated endocytosis, localizes in the cytosol and exhibits cytotoxicity","volume":"66","author":"Jang","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.3390\/v7092863","article-title":"Preventive Activity against Influenza (H1N1) Virus by Intranasally Delivered RNA-Hydrolyzing Antibody in Respiratory Epithelial Cells of Mice","volume":"7","author":"Cho","year":"2015","journal-title":"Viruses"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbrc.2010.04.032","article-title":"An RNA-hydrolyzing recombinant antibody exhibits an antiviral activity against classical swine fever virus","volume":"395","author":"Jun","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.yrtph.2018.02.012","article-title":"Survival of Escherichia coli harboring nucleic acid-hydrolyzing 3D8 scFv during RNA virus infection","volume":"94","author":"Park","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e13399","DOI":"10.1111\/asj.13399","article-title":"Administration of L. salivarius expressing 3D8 scFv as a feed additive improved the growth performance, immune homeostasis, and gut microbiota of chickens","volume":"91","author":"Sureshkumar","year":"2020","journal-title":"Anim. Sci. J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s13205-019-1811-8","article-title":"Oral administration of Lactobacillus reuteri expressing a 3D8 single-chain variable fragment (scFv) enhances chicken growth and conserves immune homeostasis","volume":"9","author":"Sureshkumar","year":"2019","journal-title":"3 Biotech."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Cho, S., Kim, D., Lee, Y., Kil, E.J., Cho, M.J., Byun, S.J., Cho, W.K., and Lee, S. (2018). Probiotic Lactobacillus Paracasei Expressing a Nucleic Acid-Hydrolyzing Minibody (3D8 Scfv) Enhances Probiotic Activities in Mice Intestine as Revealed by Metagenomic Analyses. Genes, 9.","DOI":"10.3390\/genes9060276"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbrc.2008.12.051","article-title":"Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting","volume":"379","author":"Kim","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.molimm.2014.10.009","article-title":"Generation of a chickenized catalytic anti-nucleic acid antibody by complementarity-determining region grafting","volume":"63","author":"Roh","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2008.09.061","article-title":"Optimized stability retention of a monoclonal antibody in the PLGA nanoparticles","volume":"368","author":"Son","year":"2009","journal-title":"Int. J. Pharm."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11240-013-0351-x","article-title":"RNA virus accumulation is inhibited by ribonuclease activity of 3D8 scFv in transgenic Nicotiana tabacum","volume":"115","author":"Lee","year":"2013","journal-title":"Plant Cell Tissue Organ. Cult. (PCTOC)"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11105-015-0915-5","article-title":"A Codon-Optimized Nucleic Acid Hydrolyzing Single-Chain Antibody Confers Resistance to Chrysanthemums Against Chrysanthemum Stunt Viroid Infection","volume":"34","author":"Tran","year":"2016","journal-title":"Plant Mol. Biol. Rep."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1038\/s41598-017-05270-8","article-title":"Transgenic Chickens Expressing the 3D8 Single Chain Variable Fragment Protein Suppress Avian Influenza Transmission","volume":"7","author":"Yuk","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.rvsc.2019.01.025","article-title":"The 3D8 single chain variable fragment protein suppress infectious bronchitis virus transmission in the transgenic chickens","volume":"123","author":"Lee","year":"2019","journal-title":"Res. Vet. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Byun, S.J., Choi, H., Sureshkumar, S., Yuk, S.-S., Kwon, J.-H., Noh, J.-Y., Jung, S.K., Kim, J.S., Oh, K.B., and Yang, H. (2020). The 3D8 single chain variable fragment protein suppresses Newcastle disease virus transmission in transgenic chickens. BMC Vet. Res., 16.","DOI":"10.1186\/s12917-020-02462-9"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Lee, G., Budhathoki, S., Lee, G.Y., Oh, K.J., Ham, Y.K., Kim, Y.J., Lim, Y.R., Hoang, P.T., Lee, Y., and Lim, S.W. (2021). Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro. Viruses, 13.","DOI":"10.1101\/2020.11.25.398909"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11240-013-0357-4","article-title":"A nucleic acid hydrolyzing recombinant antibody confers resistance to curtovirus infection in tobacco","volume":"115","author":"Lee","year":"2013","journal-title":"Plant Cell Tissue Organ. Cult. (PCTOC)"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41592-021-01124-4","article-title":"Programmable RNA editing with compact CRISPR\u2013Cas13 systems from uncultivated microbes","volume":"18","author":"Xu","year":"2021","journal-title":"Nat. Methods"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/8\/1552\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:24Z","timestamp":1760140824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/8\/1552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,31]]},"references-count":142,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["microorganisms10081552"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms10081552","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,31]]}}}